Profile
| Metric | Value |
|---|---|
| Full Name | Janux Therapeutics, Inc. |
| Ticker | NASDAQ: JANX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | januxrx.com |
| Employees | 91 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $13.07 | |
| Price, 1D Change | +7.31% | |
| $786M | ||
| - | ||
| - | ||
| 1.23 | ||
| $11M | ||
| Revenue, 1Y Change | +30.99% | |
| -$1.28 | ||
| EPS, 1Y Change | +3.08% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.28 | ||
| EPS Estimate | -$1.97 | |
| EPS Est. Change | -53.26% | |
| $10.59M | ||
| Revenue Estimate | $10.07M | |
| Revenue Est. Change | -4.92% | |
| Current Price | $13.07 | |
| Price Target | - | $57.00 |
| Price Tgt. Change | - | +336.11% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.53 | -$1.32 | +13.44% | |
| -$1.30 | -$1.28 | +1.59% | |
| -$1.97 | N/A | -53.26% | |
| -$2.97 | N/A | -131.65% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $6.36M | $8.08M | +27.09% | |
| $12.44M | $10.59M | -14.88% | |
| $10.07M | N/A | -4.92% | |
| $1.77M | N/A | -83.31% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $13.07 | |
| $23.15 | ||
| SMA 200 vs Price | +77.09% | |
| $15.96 | ||
| SMA 50 vs Price | +22.12% | |
| 1.23 | ||
| $0.82 | ||
| 39.84 | ||
| 67.63% | ||
| 80.94% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $10.59M | ||
| -$1.28 | ||
| $8.53M | ||
| 80.54% | ||
| -$98.85M | ||
| -933.58% | ||
| -$68.99M | ||
| -651.62% | ||
| -$96.79M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 59.21 | ||
| 59.21 | ||
| - | ||
| 3 | ||
| 12.71 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 78.61 | ||
| 0.81 | ||
| 1.27 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $1.02B | ||
| $430.61M | ||
| $1.06B | ||
| $1.03B | ||
| $38.74M | ||
| $17.46M | ||
| $23.03M | ||
| $1.75M | ||
| $4.03M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $109.44M | ||
| $109.44M | ||
| $2.06M | ||
| $41.05M | ||
| $2.06M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$43.81M | ||
| -$258.02M | ||
| $713.24M | ||
| $359.00K | ||
| -$44.17M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Clear Street | → | |
| Piper Sandler | → | |
| Barclays | → | |
| Stifel | → | |
| HC Wainwright & Co. | → | |
| Clear Street | → | |
| Cantor Fitzgerald | → | |
| B of A Securities | → | |
| HC Wainwright & Co. | → | |
| Wolfe Research |
Analyst sentiment
Institutional ownership
Screeners with JANX
FAQ
What is the ticker symbol for Janux Therapeutics, Inc.?
The ticker symbol for Janux Therapeutics, Inc. is NASDAQ:JANX
Does Janux Therapeutics, Inc. pay dividends?
No, Janux Therapeutics, Inc. does not pay dividends
What sector is Janux Therapeutics, Inc. in?
Janux Therapeutics, Inc. is in the Healthcare sector
What industry is Janux Therapeutics, Inc. in?
Janux Therapeutics, Inc. is in the Biotechnology industry
What country is Janux Therapeutics, Inc. based in?
Janux Therapeutics, Inc. is headquartered in United States
When did Janux Therapeutics, Inc. go public?
Janux Therapeutics, Inc. initial public offering (IPO) was on June 11, 2021
Is Janux Therapeutics, Inc. in the S&P 500?
No, Janux Therapeutics, Inc. is not included in the S&P 500 index
Is Janux Therapeutics, Inc. in the NASDAQ 100?
No, Janux Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Janux Therapeutics, Inc. in the Dow Jones?
No, Janux Therapeutics, Inc. is not included in the Dow Jones index
When was Janux Therapeutics, Inc. last earnings report?
Janux Therapeutics, Inc.'s most recent earnings report was on November 6, 2025
When does Janux Therapeutics, Inc. report earnings?
The next expected earnings date for Janux Therapeutics, Inc. is February 26, 2026
Data Sources & References
- JANX Official Website www.januxrx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1817713/000119312525269799/0001193125-25-269799-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1817713/000095017025029177/0000950170-25-029177-index.htm
- JANX Profile on Yahoo Finance finance.yahoo.com/quote/JANX
- JANX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/janx